Package 16571-167-01

Brand: doxazosin

Generic: doxazosin
NDC Package

Package Facts

Identity

Package NDC 16571-167-01
Digits Only 1657116701
Product NDC 16571-167
Product ID 16571-167_c7ae6273-26c7-4116-a42a-5c82e1b59849
Description

100 TABLET in 1 BOTTLE (16571-167-01)

Marketing

Marketing Status
Marketed Since 2024-05-20
Brand doxazosin
Generic doxazosin
Sample Package No

Linked Drug Pages (1)

Doxazosin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c7ae6273-26c7-4116-a42a-5c82e1b59849", "openfda": {"upc": ["0316571168019"], "unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["508b908e-8d80-422e-8ec0-2081185f4c95"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16571-167-01)", "package_ndc": "16571-167-01", "marketing_start_date": "20240520"}], "brand_name": "Doxazosin", "product_id": "16571-167_c7ae6273-26c7-4116-a42a-5c82e1b59849", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "16571-167", "generic_name": "Doxazosin", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "ANDA212727", "marketing_category": "ANDA", "marketing_start_date": "20240520", "listing_expiration_date": "20261231"}